Specialized Medical Company (TADAWUL:4019)
16.47
-0.16 (-0.96%)
Sep 3, 2026, 3:13 PM AST
TADAWUL:4019 Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, TADAWUL:4019 stock has a consensus rating of "Strong Buy" and an average price target of SAR 24.53. The average 1-year stock price forecast is 48.94% higher than the current stock price, while the lowest is SAR 21.00 (+27.50%) and the highest is SAR 30.00 (+82.15%).
Price Target: SAR 24.53 (+48.94%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4019 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 2 | 2 | 2 | 3 |
Financial Forecast
Revenue This Year
1.68B
from 1.54B
Increased by 9.14%
Revenue Next Year
1.79B
from 1.68B
Increased by 6.87%
EPS This Year
0.87
EPS Next Year
1.12
from 0.87
Increased by 28.35%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.